BRIEF-Janssen Inc says Health Canada issued notice of compliance with conditions approving Darzalex

Thu Jun 30, 2016 7:12am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 30 (Reuters) - Johnson & Johnson

* Janssen Inc says Health Canada has issued a notice of compliance with conditions approving Darzalex

* Janssen Inc says Darzalex approved by Health Canada for for treatment of multiple Myeloma

* Janssen Inc says product approved on condition that co carries out confirmatory trials to verify clinical benefit of Darzalex Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)